Neurotrauma: A Futuristic Perspective
Received: 08 January 2019
Accepted: 15 January 2019
13 August 2019 (eFirst)
The most heterogeneous and complex condition among disorders of the central nervous system (CNS) happens to be traumatic brain injury (TBI). It is poised to become the third most common cause of death and disability worldwide. The failure rate of clinical trials pertaining to TBI is 100%, and till date it lacks specific therapy. The current approach of analyzing small, representative, curated data fails to provide a definite solution. Napoleon Bonaparte once said, “War is 90 percent information.” In present-day context, gathering and collating the collected TBI data remains the key to solve mystery of TBI. And no doubt, TBI needs to be attacked on a war footing. The fourth industrial revolution is showing us ways of tackling this most complex disease, of the most complex organ.
Recent buzzwords such as big data analytics (BDA), fuzzy logic (FL), artificial intelligence (AI), brain-computer interface, radiomics, pharmacogenomics and precision medicine, and biologic and immune modulation therapy are increasingly being incorporated into neurosciences. This paper attempts to analyze the current status and future role that these futuristic technologies will play in our conquest against TBI.
An honest attempt has been made to understand the current status of the ongoing technological revolution and predict its impact on management of TBI. It is certain that very soon newer approaches will transform the current practice of triage, diagnosis, treatment, and prognosis of TBI into a highly integrated, evidence-based patient care. In addition, it will also cut down the cost of health care significantly.
- 1 Agoston & Langford, Big Data in traumatic brain injury; promise and challenges. Future science group. Available at www.futuremedicine.com Accessed December 27, 2018
- 2 Rumsfeld JS, Joynt KE, Maddox TM. Big data analytics to improve cardiovascular care: promise and challenges. Nat Rev Cardiol 2016; 13 (06) 350-359
- 3 Morgan J. David Menon: the incredible, incurable, clinical rationalist. Lancet Neurol 2017; 16 (10) 775
- 4 Shrestha GS, Suarez JI, Hemphill III JC. Precision medicine in neurocritical care. JAMA Neurol 2018; 75 (12) 1463-1464
- 5 Winn HR, Howard MA. The next 100 years of neurosurgery. Lancet 1999; 354 (Suppl) SIV36
- 6 Epilepsy Foundation. FDA approves responsive neurostimulation therapy by Neuropace. November 14, 2013. Available at: https://www.epilepsy.com/release/2014/3/fda-approves-responsive-neurostimulation-therapy-neuropace Accessed December 27, 2018
- 7 George R, Mayr C, Indiveri G, Vassanelli S. Event-based softcore processor in a biohybrid setup applied to structural plasticity. In: 2015 International Conference on Event-Based Control, Communication, and Signal Processing (EBCCSP). Krakow, Poland: 2015: 1-4
- 8 Li Q, Serb A, Prodromakis T, Xu H. A memristor SPICE model accounting for synaptic activity dependence. PLoS One 2015; 10 (03) e0120506
- 9 Orsborn AL, Moorman HG, Overduin SA, Shanechi MM, Dimitrov DF, Carmena JM. Closed-loop decoder adaptation shapes neural plasticity for skillful neuroprosthetic control. Neuron 2014; 82 (06) 1380-1393
- 10 Borton D, Micera S, Millán JdelR, Courtine G. Personalized neuroprosthetics. Sci Transl Med 2013; 5 (210) 210rv2